• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于早期检测外周血中乳腺癌的多种生物标志物组合

Multiple biomarker panels for early detection of breast cancer in peripheral blood.

作者信息

Zhang Fan, Deng Youping, Drabier Renee

机构信息

Department of Academic and Institutional Resources and Technology, University of North Texas Health Science Center, Fort Worth, 76107, USA ; Department of Forensic and Investigative Genetics, University of North Texas Health Science Center, Fort Worth, 76107, USA.

Department of Internal Medicine Kidston House, Rush University Medical Center, 630 S. Hermitage Avenue, Room 408, Chicago, IL 60612, USA.

出版信息

Biomed Res Int. 2013;2013:781618. doi: 10.1155/2013/781618. Epub 2013 Nov 26.

DOI:10.1155/2013/781618
PMID:24371830
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3858861/
Abstract

Detecting breast cancer at early stages can be challenging. Traditional mammography and tissue microarray that have been studied for early breast cancer detection and prediction have many drawbacks. Therefore, there is a need for more reliable diagnostic tools for early detection of breast cancer due to a number of factors and challenges. In the paper, we presented a five-marker panel approach based on SVM for early detection of breast cancer in peripheral blood and show how to use SVM to model the classification and prediction problem of early detection of breast cancer in peripheral blood. We found that the five-marker panel can improve the prediction performance (area under curve) in the testing data set from 0.5826 to 0.7879. Further pathway analysis showed that the top four five-marker panels are associated with signaling, steroid hormones, metabolism, immune system, and hemostasis, which are consistent with previous findings. Our prediction model can serve as a general model for multibiomarker panel discovery in early detection of other cancers.

摘要

早期检测乳腺癌具有挑战性。用于早期乳腺癌检测和预测的传统乳房X线摄影术和组织微阵列存在许多缺点。因此,由于多种因素和挑战,需要更可靠的诊断工具来早期检测乳腺癌。在本文中,我们提出了一种基于支持向量机的五标记物组合方法用于外周血中乳腺癌的早期检测,并展示了如何使用支持向量机对外周血中乳腺癌早期检测的分类和预测问题进行建模。我们发现,五标记物组合可将测试数据集中的预测性能(曲线下面积)从0.5826提高到0.7879。进一步的通路分析表明,排名前四的五标记物组合与信号传导、类固醇激素、代谢、免疫系统和止血相关,这与之前的研究结果一致。我们的预测模型可作为在其他癌症早期检测中发现多生物标志物组合的通用模型。

相似文献

1
Multiple biomarker panels for early detection of breast cancer in peripheral blood.用于早期检测外周血中乳腺癌的多种生物标志物组合
Biomed Res Int. 2013;2013:781618. doi: 10.1155/2013/781618. Epub 2013 Nov 26.
2
Recursive SVM biomarker selection for early detection of breast cancer in peripheral blood.递归支持向量机生物标志物选择用于外周血乳腺癌的早期检测。
BMC Med Genomics. 2013;6 Suppl 1(Suppl 1):S4. doi: 10.1186/1755-8794-6-S1-S4. Epub 2013 Jan 23.
3
Circulating micro-RNAs as potential blood-based markers for early stage breast cancer detection.循环 microRNAs 作为早期乳腺癌检测的潜在血液标志物。
PLoS One. 2012;7(1):e29770. doi: 10.1371/journal.pone.0029770. Epub 2012 Jan 5.
4
Diagnostic Value of Nonacid Nucleic Blood Tumor Marker Panels in Early Diagnosing Breast Cancer: A Systematic Review and Network Meta-Analysis.非酸性核酸血液肿瘤标志物联合检测对早期诊断乳腺癌的诊断价值:系统评价和网络荟萃分析。
Dis Markers. 2022 Feb 3;2022:4119345. doi: 10.1155/2022/4119345. eCollection 2022.
5
Robust edge-based biomarker discovery improves prediction of breast cancer metastasis.基于稳健边缘的生物标志物发现可提高乳腺癌转移的预测能力。
BMC Bioinformatics. 2020 Sep 30;21(Suppl 14):359. doi: 10.1186/s12859-020-03692-2.
6
The future of blood-based biomarkers for the early detection of breast cancer.用于早期检测乳腺癌的基于血液的生物标志物的未来。
Eur J Cancer. 2018 Mar;92:54-68. doi: 10.1016/j.ejca.2017.12.025. Epub 2018 Feb 6.
7
A Novel Computational Approach for Biomarker Detection for Gene Expression-Based Computer-Aided Diagnostic Systems for Breast Cancer.一种用于基于基因表达的计算机辅助诊断系统的生物标志物检测的新型计算方法。
Methods Mol Biol. 2021;2190:195-208. doi: 10.1007/978-1-0716-0826-5_9.
8
Biomarker Studies in Early Detection and Prognosis of Breast Cancer.生物标志物在乳腺癌早期检测和预后中的研究。
Adv Exp Med Biol. 2017;1026:27-39. doi: 10.1007/978-981-10-6020-5_2.
9
Identifying cancer biomarkers by network-constrained support vector machines.通过网络约束支持向量机识别癌症生物标志物。
BMC Syst Biol. 2011 Oct 12;5:161. doi: 10.1186/1752-0509-5-161.
10
Assessment of a six gene panel for the molecular detection of circulating tumor cells in the blood of female cancer patients.评估六个基因panel 用于女性癌症患者血液中循环肿瘤细胞的分子检测。
BMC Cancer. 2010 Dec 3;10:666. doi: 10.1186/1471-2407-10-666.

引用本文的文献

1
Assessment of lipid peroxidation and total antioxidant capacity in patients with breast cancer.乳腺癌患者脂质过氧化和总抗氧化能力的评估。
Explor Target Antitumor Ther. 2025 Jan 2;6:1002284. doi: 10.37349/etat.2025.1002284. eCollection 2025.
2
Blood-Based mRNA Tests as Emerging Diagnostic Tools for Personalised Medicine in Breast Cancer.基于血液的mRNA检测作为乳腺癌个性化医疗的新兴诊断工具
Cancers (Basel). 2023 Feb 8;15(4):1087. doi: 10.3390/cancers15041087.
3
Identification of Cell-Free Circulating MicroRNAs for the Detection of Early Breast Cancer and Molecular Subtyping.

本文引用的文献

1
IPAD: the Integrated Pathway Analysis Database for Systematic Enrichment Analysis.IPAD:系统富集分析的综合途径分析数据库。
BMC Bioinformatics. 2012;13 Suppl 15(Suppl 15):S7. doi: 10.1186/1471-2105-13-S15-S7. Epub 2012 Sep 11.
2
Discovery of pathway biomarkers from coupled proteomics and systems biology methods.从耦合蛋白质组学和系统生物学方法中发现途径生物标志物。
BMC Genomics. 2010 Nov 2;11 Suppl 2(Suppl 2):S12. doi: 10.1186/1471-2164-11-S2-S12.
3
Gene expression profiling of peripheral blood cells for early detection of breast cancer.
用于早期乳腺癌检测和分子分型的游离循环微小RNA的鉴定
J Oncol. 2019 Aug 8;2019:8393769. doi: 10.1155/2019/8393769. eCollection 2019.
4
Trefoil factor(s) and CA19.9: A promising panel for early detection of pancreatic cancer.三叶因子和 CA19.9:用于早期检测胰腺癌的有前途的标志物组合。
EBioMedicine. 2019 Apr;42:375-385. doi: 10.1016/j.ebiom.2019.03.056. Epub 2019 Apr 5.
5
Albumin and hemoglobin adducts of estrogen quinone as biomarkers for early detection of breast cancer.雌激素醌白蛋白和血红蛋白加合物作为乳腺癌早期检测的生物标志物。
PLoS One. 2018 Sep 17;13(9):e0201241. doi: 10.1371/journal.pone.0201241. eCollection 2018.
6
Cell Cycle Model System for Advancing Cancer Biomarker Research.细胞周期模型系统在推进癌症生物标志物研究中的应用。
Sci Rep. 2017 Dec 21;7(1):17989. doi: 10.1038/s41598-017-17845-6.
7
Clinical applications of quantitative proteomics using targeted and untargeted data-independent acquisition techniques.使用靶向和非靶向数据非依赖型采集技术的定量蛋白质组学的临床应用
Expert Rev Proteomics. 2017 May;14(5):419-429. doi: 10.1080/14789450.2017.1322904.
8
CombiROC: an interactive web tool for selecting accurate marker combinations of omics data.CombiROC:一种交互式网络工具,用于选择组学数据的准确标记组合。
Sci Rep. 2017 Mar 30;7:45477. doi: 10.1038/srep45477.
外周血细胞基因表达谱分析用于乳腺癌的早期检测。
Breast Cancer Res. 2010;12(1):R7. doi: 10.1186/bcr2472. Epub 2010 Jan 15.
4
Comparative serum proteome analysis of human lymph node negative/positive invasive ductal carcinoma of the breast and benign breast disease controls via label-free semiquantitative shotgun technology.通过无标记半定量鸟枪法技术对人乳腺淋巴结阴性/阳性浸润性导管癌及良性乳腺疾病对照进行血清蛋白质组比较分析。
OMICS. 2009 Aug;13(4):291-300. doi: 10.1089/omi.2009.0016.
5
Diagnosis of breast cancer by tear proteomic pattern.通过泪液蛋白质组图谱诊断乳腺癌。
Cancer Genomics Proteomics. 2009 May-Jun;6(3):177-82.
6
Proteomic analysis of archival breast cancer serum.存档乳腺癌血清的蛋白质组学分析
Cancer Genomics Proteomics. 2009 May-Jun;6(3):141-7.
7
Gene expression profiling of human lymph node metastases and matched primary breast carcinomas: clinical implications.人淋巴结转移灶及配对原发性乳腺癌的基因表达谱分析:临床意义
Mol Oncol. 2007 Sep;1(2):172-80. doi: 10.1016/j.molonc.2007.03.005. Epub 2007 Apr 7.
8
Prediction of breast cancer by profiling of urinary RNA metabolites using Support Vector Machine-based feature selection.基于支持向量机的特征选择通过尿液RNA代谢物分析预测乳腺癌。
BMC Cancer. 2009 Apr 5;9:104. doi: 10.1186/1471-2407-9-104.
9
An overview of statistical learning theory.统计学习理论概述。
IEEE Trans Neural Netw. 1999;10(5):988-99. doi: 10.1109/72.788640.
10
Breast cancer: origins and evolution.乳腺癌:起源与演变
J Clin Invest. 2007 Nov;117(11):3155-63. doi: 10.1172/JCI33295.